GL1X · GenesisL1 explorer

Research workbench

Group deposition for crystallographic fragment screening of Coxsackievirus A16 (G-10) 2A protease -- Crystal structure of Coxsackievirus A16 (G-10) 2A protease in complex with Z1456069604 (A71EV2A-x0269)

Analyse Group deposition for crystallographic fragment screening of Coxsackievirus A16… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7H32
Type
protein
Length
140 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.28
Source
Coxsackievirus A16
Molecule
Protease 2A
EC
3.4.22.29
UniProt
Q65900
Ligands
89W, ZN, SO4
Pockets
1 · best druggability 0.42

Structure

x-ray diffraction · resolution 1.28 · 1 distinct chain · 15% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtease 2A (EC 3.4.22.29)protein14015% helix, 54% strandQ65900

Ligands and binding sites

  • 89W · N-[(3R)-piperidin-3-yl]benzamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • SO4 · Sulfate ion · ion
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1900.420.7826empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.